These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3768408)

  • 1. Inactivation of acetylcholinesterase with a bretylium tosylate photoaffinity probe.
    Branchini BR; Lajiness EJ
    Biochim Biophys Acta; 1986 Oct; 884(1):135-41. PubMed ID: 3768408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibition of acetylcholinesterase by bretylium: possible mechanism for its induction of norepinephrine release.
    Schreiber G; Sokolovsky M
    J Cardiovasc Pharmacol; 1985; 7(6):1065-8. PubMed ID: 2418289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and intravenous bretylium disposition.
    Anderson JL; Patterson E; Wagner JG; Stewart JR; Behm HL; Lucchesi BR
    Clin Pharmacol Ther; 1980 Oct; 28(4):468-78. PubMed ID: 7408407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of bretylium tosylate with rat cardiac muscarinic receptors. Possible pharmacological relevance to antiarrhythmic action.
    Schreiber G; Friedman M; Sokolovsky M
    Circ Res; 1984 Nov; 55(5):653-9. PubMed ID: 6488487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of [14C]bretylium tosylate in rats.
    Kamath BL; Stampfli HF; Lai CM; Yacobi A
    J Pharm Sci; 1981 Jun; 70(6):667-9. PubMed ID: 7252812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution of [14C]bretylium tosylate in rats.
    Yacobi A; Kamath BL; Lai CM; Stampfli HF
    J Pharm Sci; 1983 May; 72(5):556-9. PubMed ID: 6864505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium opens mucosal amiloride-sensitive sodium channels.
    Ilani A; Lichtstein D; Bacaner MB
    Biochim Biophys Acta; 1982 Dec; 693(2):503-6. PubMed ID: 6297561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
    Schreiber G; Sokolovsky M
    Mol Pharmacol; 1985 Jan; 27(1):27-31. PubMed ID: 3965929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of bretylium tosylate on the intraocular pressure of the rabbit.
    Krieglstein GK
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
    Mirro MJ; Webel RR; Kelly KJ; Grina LA
    J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between bretylium and diphenylhydantoin interaction with mucosal sodium-channels.
    Ilani A; Yachin S; Lichtstein D
    Biochim Biophys Acta; 1984 Nov; 777(2):323-30. PubMed ID: 6091758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC; Allen JD; Pantridge JF
    Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bretylium tosylate enhances salt taste.
    Schiffman SS; Simon SA; Gill JM; Beeker TG
    Physiol Behav; 1986; 36(6):1129-37. PubMed ID: 3725917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of bretylium tosylate in a single bolus and in different doses on various electrophysiological parameters].
    Chiariello M; Santinelli V; Ferro G; Stanislao M; Giunta A; Condorelli M
    Boll Soc Ital Cardiol; 1979; 24(7):747-51. PubMed ID: 554660
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of bretylium in dogs and the effect of hemoperfusion on elimination.
    Kamath BL; Gibson TP; Look ZM; McEntegart CM; Comrie EB; Yacobi A
    J Pharm Sci; 1982 Nov; 71(11):1294-6. PubMed ID: 7175729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of bretylium in man after intravenous administration.
    Narang PK; Adir J; Josselson J; Yacobi A; Sadler J
    J Pharmacokinet Biopharm; 1980 Aug; 8(4):363-72. PubMed ID: 7431227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.